Fulcrum Therapeutics, Inc.
Recent Filings
All 468 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 10-K | 10-K | Feb 24, 2026 |
| 8-K | 8-K | Feb 24, 2026 |
| S-8 | S-8 | Feb 24, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 4 | 4 | Feb 4, 2026 |
| 4 | 4 | Feb 4, 2026 |
| 4 | 4 | Feb 4, 2026 |
| 4 | 4 | Feb 4, 2026 |
| 4/A | 4/A | Feb 4, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Oltmans Curtis Gale | Chief Legal Officer | Sale | 3,452 @ $12.92 | Dec 15, 2025 |
| RA Capital Healthcare Fund LP | — | Sale | 2,706,397 @ $14.28 | Dec 8, 2025 |
| Gould Robert J | — | Sale | 15,000 @ $11.03 | Nov 19, 2025 |
| Tourangeau Greg | Principal Accounting Officer | Sale | 498 @ $5.06 | May 8, 2025 |
| Tourangeau Greg | Principal Accounting Officer | Sale | 236 @ $7.76 | May 7, 2024 |
| Tourangeau Greg | Vice President, Finance | Sale | 4,884 @ $11.72 | Mar 8, 2024 |
| Sapir Alex | See Remarks | Purchase | 43,360 @ $11.35 | Mar 4, 2024 |
| Tourangeau Greg | Principal Accounting Officer | Sale | 210 @ $3.31 | May 10, 2023 |
| RA CAPITAL MANAGEMENT, L.P. | — | Purchase | 1,923,076 @ $13.00 | Jan 20, 2023 |
| Gould Robert J | Interim President & CEO | Sale | 6,766 @ $15.00 | Jan 13, 2023 |